HyGIeaCare, Inc.
7
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
42.9%
3 terminated/withdrawn out of 7 trials
57.1%
-29.4% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Microbiome Analysis of Constipated Versus Non-constipation Patients
Role: lead
Assessing Uniqueness of Inflammatory Bowel Disease Related Microbiome-derived Biomarkers
Role: lead
HygiRelief Procedure and HygiSample Evaluation for Functional Constipation
Role: lead
Use of a Colon Irrigation Device as a Preparation for a Colon Visualization Procedure
Role: lead
Evaluation of Stool Microbiome Using HyGIeaCare Prep
Role: lead
HyGIeaCare Prep vs Split-dose PEG Prep Prior to Colonoscopy
Role: lead
HyGIeaCare Procedure for Chronic Constipation
Role: lead
All 7 trials loaded